D. Kounatidis

发表

Diabetes mellitus in the era of climate change.

M. Dalamaga, S. Dourakis, N. Vallianou, 2020, Diabetes & metabolism.

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem

M. Dalamaga, N. Vallianou, D. Kounatidis, 2021, Metabolism Open.

Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future Perspectives

M. Dalamaga, N. Vallianou, E. Geladari, 2022, Current Nutrition Reports.

Severe eosinophilic granulomatosis with polyangiitis responding to a combination of rituximab and mepolizumab.

Nektarios Koufopoulos, A. Antoniadou, N. Vallianou, 2022, The American journal of the medical sciences.

The Role of the Respiratory Microbiome in the Pathogenesis of Aspiration Pneumonia: Implications for Diagnosis and Potential Therapeutic Choices

N. Vallianou, E. Geladari, D. Kounatidis, 2023, Antibiotics.

Bacteroides fragilis vertebral osteomyelitis: A rare clinical entity.

E. Papageorgiou, N. Vallianou, D. Kounatidis, 2022, Anaerobe.

Mycobiome and Cancer: What Is the Evidence?

M. Dalamaga, N. Vallianou, D. Kounatidis, 2021, Cancers.

Microbiome and hypertension: where are we now?

N. Vallianou, E. Geladari, D. Kounatidis, 2019, Journal of cardiovascular medicine.

Effects of T3 Administration on Ex Vivo Rat Hearts Subjected to Normothermic Perfusion: Therapeutic Implications in Donor Heart Preservation and Repair

A. Lourbopoulos, I. Mourouzis, C. Pantos, 2023, Transplant International.

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives

F. Magkos, M. Dalamaga, N. Vallianou, 2021, Biomolecules.

Clostridioides difficile infection in a patient with immunoglobulin A vasculitis: a triggering factor or a rare complication of the disease? A case-based review

N. Vallianou, D. Kounatidis, F. Panagopoulos, 2020, Rheumatology International.

Diabetes mellitus and SARS-CoV-2 infection: pathophysiologic mechanisms and implications in management.

M. Dalamaga, N. Vallianou, D. Kounatidis, 2020, Current diabetes reviews.

Pure red cell aplasia caused by azathioprine: case report and review of the literature.

N. Vallianou, D. Kounatidis, C. Masaoutis, 2020, Cardiovascular & Haematological Disorders - Drug Targets.

The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives

M. Dalamaga, N. Vallianou, D. Kounatidis, 2023, International journal of molecular sciences.

SGLT-2 inhibitors in obesity and its associated cardiometabolic disorders: where do we stand?

M. Dalamaga, N. Vallianou, D. Kounatidis, 2022, Polish archives of internal medicine.

SGLT-2 Inhibitors and the Inflammasome: What’s Next in the 21st Century?

I. Mourouzis, N. Vallianou, D. Kounatidis, 2023, Nutrients.

An HHV-8 Positive HIV Negative Multicentric Castleman's Disease, Who Responded Well to Rituximab Alone.

D. Rontogianni, N. Vallianou, D. Kounatidis, 2020, Cardiovascular & Haematological Disorders - Drug Targets.

Immunotherapy in Head and Neck Cancer: Where Do We Stand?

M. Dalamaga, N. Vallianou, E. Geladari, 2023, Current Oncology Reports.

Gut Microbiota and Its Role in the Brain-Gut-Kidney Axis in Hypertension

M. Dalamaga, N. Vallianou, E. Geladari, 2023, Current Hypertension Reports.

ApoB100 and Atherosclerosis: What’s New in the 21st Century?

M. Dalamaga, N. Vallianou, E. Geladari, 2024, Metabolites.

Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges

M. Dalamaga, N. Vallianou, D. Kounatidis, 2023, Current obesity reports.

Sepsis-Associated Acute Kidney Injury: Where Are We Now?

N. Vallianou, D. Kounatidis, T. Stratigou, 2024, Medicina.

Third-Generation Tetracyclines: Current Knowledge and Therapeutic Potential

N. Vallianou, D. Kounatidis, I. Karampela, 2024, Biomolecules.

Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?

N. Vallianou, D. Kounatidis, A. Poulaki, 2024, International journal of molecular sciences.

NAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics

N. Vallianou, E. Geladari, D. Kounatidis, 2024, Biomedicines.

The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies

I. Mourouzis, N. Vallianou, D. Kounatidis, 2024, Metabolites.

Autoimmune polyglandular syndrome with shock and high anion gap metabolic acidosis.

N. Vallianou, D. Kounatidis, Evangelia Kotsi, 2024, The American journal of the medical sciences.

Pneumocystosis in a patient with rheumatoid arthritis on adalimumab therapy: a case-based review

N. Vallianou, D. Kounatidis, V. Papadimitropoulos, 2023, Rheumatology international.

25-hydroxyvitamin D and parathyroid hormone in new onset sepsis: A prospective study in critically ill patients

N. Vallianou, D. Kounatidis, T. Stratigou, 2024, Metabolism open.

The Kidney in Obesity: Current Evidence, Perspectives and Controversies.

N. Vallianou, D. Kounatidis, T. Stratigou, 2024, Current obesity reports.

The Interplay Between Dietary Choline and Cardiometabolic Disorders: A Review of Current Evidence

N. Vallianou, E. Geladari, D. Kounatidis, 2024, Current nutrition reports.